Systems biology and theranostic approach to drug discovery and development to treat traumatic brain injury

Methods in Molecular Biology

Volumn 662, Issue , 2010, Pages 317-329

  Zhang, Zhiqun ^b   Larner, Stephen F ^b   Kobeissy, Firas ^a   Hayes, Ronald L ^b   Wang, Kevin K W ^a,b  

^a UNIVERSITY OF FLORIDA HEALTH   (United States)

^b BANYAN BIOMARKERS INC   (United States)

Author keywords

Biomarkers; Brain injury; Systems biology; Theranostics

Indexed keywords

EID: 84934434892     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-60761-800-3_16     Document Type: Article

References (22)

1. Wang KK, Larner SF, Robinson G, Hayes RL (2006) Neuroprotection targets after traumatic brain injury. Curr Opin Neurol 19:514-519
2. Chen SS, Haskins WE, Ottens AK, Hayes RL, Denslow ND, Wang KKW (2007) Bioinformatics for traumatic brain injury: proteimic data mining. In: Pardalos PM, Boginski VL, Vazacopoulos A (eds) Data mining in biomedicine. Springer, New York, pp 1-26
3. Beltrao P, Kiel C, Serrano L (2007) Structures in systems biology. Curr Opin Struct Biol 17:378-384
4. Bader GD, Betel D, Hogue CW (2003) BIND: the Biomolecular Interaction Network Database. Nucleic Acids Res 31:248-250
5. Jayapandian M, Chapman A, Tarcea VG, Yu C, Elkiss A, Ianni A, Liu B, Nandi A, Santos C, Andrews P, Athey B, States D, Jagadish HV (2007) Michigan Molecular Interactions (MiMI): putting the jigsaw puzzle together. Nucleic Acids Res 35:D566-D571
6. Vastrik I, D'Eustachio P, Schmidt E, Gopinath G, Croft D, de Bono B, Gillespie M, Jassal B, Lewis S, Matthews L, Wu G, Birney E, Stein L (2007) Reactome: a knowledge base of biologic pathways and processes. Genome Biol 8:R39
7. Hucka M, Finney A, Sauro HM, Bolouri H, Doyle JC, Kitano H, Arkin AP, Bornstein BJ, Bray D, Cornish-Bowden A, Cuellar AA, Dronov S, Gilles ED, Ginkel M, Gor V, Goryanin II, Hedley WJ, Hodgman TC, Hofmeyr JH, Hunter PJ, Juty NS, Kasberger JL, Kremling A, Kummer U, Le Novère N, Loew LM, Lucio D, Mendes P, Minch E, Mjolsness ED, Nakayama Y, Nelson MR, Nielsen PF, Sakurada T, Schaff JC, Shapiro BE, Shimizu TS, Spence HD, Stelling J, Takahashi K, Tomita M, Wagner J, Wang J, SBML Forum (2003) The systems biology markup language (SBML): a medium for representation and exchange of biochemical network models. Bioinformatics 19:524-531
8. Campagne F, Neves S, Chang CW, Skrabanek L, Ram PT, Iyengar R, Weinstein H (2004) Quantitative information management for the biochemical computation of cellular networks. Sci STKE 2004:pl11
9. Nickerson D, Hunter P (2005) Using CellML in computational models of multiscale physiology. Conf Proc IEEE Eng Med Biol Soc 6:6096-6099
10. Wang KK, Ottens AK, Liu MC, Lewis SB, Meegan C, Oli MW, Tortella FC, Hayes RL (2005) Proteomic identification of biomarkers of traumatic brain injury. Expert Rev Proteomics 2:603-614
11. Warner S (2004) Diagnostics + therapy = theranostics. The Scientist 18:38
12. Vitzthum F, Behrens F, Anderson NL, Shaw JH (2005) Proteomics: from basic research to diagnostic application. A review of requirements & needs. J Proteome Res 4:1086-1097
13. Kobeissy FH, Ottens AK, Zhang Z, Liu MC, Denslow ND, Dave JR, Tortella FC, Hayes RL, Wang KK (2006) Novel differential neuroproteomics analysis of traumatic brain injury in rats. Mol Cell Proteomics 5:1887-1898
14. Liu MC, Akle V, Zheng W, Dave JR, Tortella FC, Hayes RL, Wang KK (2006) Comparing calpain- and caspase-3-mediated degradation patterns in traumatic brain injury by differential proteome analysis. Biochem J 394:715-725
15. Kobeissy FH, Sadasivan S, Liu J, Gold MS, Wang KK (2008) Psychiatric research: psychoproteomics, degradomics and systems biology. Expert Rev Proteomics 5:293-314
16. Romeo MJ, Espina V, Lowenthal M, Espina BH, Petricoin EF III, Liotta LA (2005) CSF proteome: a protein repository for potential biomarker identification. Expert Rev Proteomics 2:57-70
17. Rifai N, Gillette MA, Carr SA (2006) Protein biomarker discovery and validation: the long and uncertain path to clinical utility. Nat Biotechnol 24:971-983
18. Pike BR, Flint J, Dutta S, Johnson E, Wang KK, Hayes RL (2001) Accumulation of nonerythroid alpha II-spectrin and calpain-cleaved alpha II-spectrin breakdown products in cerebrospinal fluid after traumatic brain injury in rats. J Neurochem 78:1297-1306
19. Ringger NC, O'Steen BE, Brabham JG, Silver X, Pineda J, Wang KK, Hayes RL, Papa L (2004) A novel marker for traumatic brain injury: CSF alphaII-spectrin breakdown product levels. J Neurotrauma 21:1443-1456
20. Pineda JA, Lewis SB, Valadka AB, Papa L, Hannay HJ, Heaton SC, Demery JA, Liu MC, Aikman JM, Akle V, Brophy GM, Tepas JJ, Wang KK, Robertson CS, Hayes RL (2007) Clinical significance of alphaII-spectrin breakdown products in cerebrospinal fluid after severe traumatic brain injury. J Neurotrauma 24:354-366
21. Hinman LM, Huang SM, Hackett J, Koch WH, Love PY, Pennello G, Torres-Cabassa A, Webster C (2006) The drug diagnostic codevelopment concept paper: commentary from the 3rd FDA-DIA-PWG-PhRMA-BIO Pharmacogenomics Workshop. Pharmacogenomics J 6:375-380
22. Katz R (2004) Biomarkers and surrogate markers: an FDA perspective. NeuroRx 1:189-195